Current Topics in Microbiology and Immunology (1993) Volume on Adhesion in Leukocyte Homing and Differentiation (eds D. Dunon, C. R. Mackay, and B. A. Imhof) CD44: a multitude of isoforms with diverse functions

The CD44 transmembrane glycoprotein of 90 kDa has been known for more than 10 years under such diverse designations as lymphocyte homing receptor (gp90Hermes), phagocytic glycoprotein (Pgp-1), extracellular matrix receptor III (ECMRIII) and hyaluronate receptor (H-CAM) (see reviews by Haynes et al. 1989 and 1991). Studies with monoclonal antibodies revealed similarity, and most likely identity, among these molecules (Omary etal. 1988; Gallatin et al. 1989; Picker et al. 1989; Aruffo et al. 1990; Miyake et al. 1990; Culty et al. 1990). When the human, baboon and murine cDNA sequences were established identity was confirmed. However, the cDNA sequence codes only for about 360 amino acids, revealing a 37 kDa protein core (Stamenkovic et al. 1989; Goldstein et al. 1989; Idzerda et al. 1989; Nottenburg et al. 1989; Zhou et al. 1989; Wolffe et al. 1990). This protein core is highly glycosylated by N- and O-linked sugars to yield a 85–90 kDa form and is sometimes additionally linked to chondroitin sulfate side chains to produce a 180–220 kDa form (Jalkanen et al. 1988; Stamenkovic et al. 1989).

[1]  P. Grabowski,et al.  Control of alternative splicing by the differential binding of U1 small nuclear ribonucleoprotein particle. , 1991, Science.

[2]  N. Fusenig,et al.  Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. , 1987, Oncogene.

[3]  W. Carter,et al.  Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons , 1991, The Journal of cell biology.

[4]  L. Picker,et al.  Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types , 1989, The Journal of cell biology.

[5]  Martin Hofmann,et al.  A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells , 1991, Cell.

[6]  J. Hornung,et al.  Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line , 1988, The Journal of cell biology.

[7]  J. R. de los Toyos,et al.  Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.

[8]  S. Jalkanen,et al.  Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin , 1992, The Journal of cell biology.

[9]  J. Bell,et al.  Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[10]  William,et al.  Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. , 1988, The Journal of biological chemistry.

[11]  M. Zöller,et al.  Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. , 1989, Cancer research.

[12]  G. Nicolson,et al.  Tumor cell instability, diversification, and progression to the metastatic phenotype: from oncogene to oncofetal expression. , 1987, Cancer research.

[13]  M. Wiles,et al.  Hematopoietic commitment during embryonic stem cell differentiation in culture. , 1993, Molecular and cellular biology.

[14]  H. Liao,et al.  The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. , 1991, Cancer cells.

[15]  C. Nottenburg,et al.  Isolation of mouse CD44 cDNA: structural features are distinct from the primate cDNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Amiot,et al.  The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate‐bearing cells. , 1991, The EMBO journal.

[17]  P. Herrlich,et al.  Retardation of metastatic tumor growth after immunization with metastasis‐specific monoclonal antibodies , 1990, International journal of cancer.

[18]  R. Abe,et al.  Characterization of autoantibody-secreting B cells in mice undergoing stimulatory (chronic) graft-versus-host reactions. Identification of a CD44hi population that binds specifically to hyaluronate. , 1991, Journal of immunology.

[19]  A. Hart,et al.  Scc-1, a novel colon cancer susceptibility gene in the mouse: linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. , 1992, Oncogene.

[20]  E. Puré,et al.  Variations in the cytoskeletal interaction and posttranslational modification of the CD44 homing receptor in macrophages , 1991, The Journal of cell biology.

[21]  G. Bepler,et al.  Characterization of the state of differentiation of six newly established human non-small-cell lung cancer cell lines. , 1988, Differentiation; research in biological diversity.

[22]  M. Zöller,et al.  Characterization of BSp73, a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. , 1983, Invasion & metastasis.

[23]  A. Datta,et al.  The complex CD44 transcriptional unit; alternative splicing of three internal exons generates the epithelial form of CD44. , 1992, Biochemical and biophysical research communications.

[24]  S. Holland,et al.  The cDNA sequence of mouse Pgp-1 and homology to human CD44 cell surface antigen and proteoglycan core/link proteins. , 1990, The Journal of biological chemistry.

[25]  I. Stamenkovic,et al.  Distinct effects of two CD44 isoforms on tumor growth in vivo , 1991, The Journal of experimental medicine.

[26]  P. Frost,et al.  Clinical implications of metastatic process , 1992, The Lancet.

[27]  W. Carter,et al.  Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Oshimura,et al.  Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. , 1992, Cancer research.

[29]  Q. He,et al.  Requirements for hyaluronic acid binding by CD44: a role for the cytoplasmic domain and activation by antibody , 1992, The Journal of experimental medicine.

[30]  E. Butcher,et al.  The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins [published erratum appears in J Cell Biol 1991 Feb;112(3):following 513] , 1990, The Journal of cell biology.

[31]  R. Akeson,et al.  At least 27 alternatively spliced forms of the neural cell adhesion molecule mRNA are expressed during rat heart development , 1991, Molecular and cellular biology.

[32]  P. Herrlich,et al.  Participation in normal immune responses of a metastasis-inducing splice variant of CD44. , 1992, Science.

[33]  I. Stamenkovic,et al.  Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein , 1992, The Journal of experimental medicine.

[34]  I. Stamenkovic,et al.  CD44H regulates tumor cell migration on hyaluronate-coated substrate , 1992, The Journal of cell biology.

[35]  C. Isacke,et al.  Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. , 1992, The EMBO journal.

[36]  P. Herrlich,et al.  CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines. , 1991, Cancer research.

[37]  P. Y. Chou,et al.  Prediction of protein conformation. , 1974, Biochemistry.

[38]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[39]  W. Carter,et al.  Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Brian Seed,et al.  A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family , 1989, Cell.

[41]  M. Mareel,et al.  Tumour invasion: effects of cell adhesion and motility. , 1992, Trends in cell biology.

[42]  N. Isola,et al.  The multispecific cell adhesion molecule CD44 is represented in reticulocyte cDNA. , 1991, Biochemical and biophysical research communications.

[43]  K. Miyake,et al.  Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition , 1990, The Journal of experimental medicine.

[44]  M. Telen,et al.  CD44--a molecule involved in leukocyte adherence and T-cell activation. , 1989, Immunology today.

[45]  D. Tarin,et al.  Significance of CD44 gene products for cancer diagnosis and disease evaluation , 1992, The Lancet.

[46]  C. Mackay,et al.  Expression and modulation of CD44 variant isoforms in humans , 1994, The Journal of cell biology.

[47]  J. Bishop,et al.  Expression of CD44 is repressed in neuroblastoma cells , 1991, Molecular and cellular biology.

[48]  J. Bell,et al.  Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. , 1992, The Journal of biological chemistry.

[49]  T. Maniatis,et al.  Mechanisms of alternative pre-mRNA splicing. , 1991, Science.

[50]  D. Goeddel,et al.  Molecular cloning and expression of Pgp-1. The mouse homolog of the human H-CAM (Hermes) lymphocyte homing receptor. , 1989, Journal of immunology.

[51]  P. Goodfellow,et al.  The gene, MIC4, which controls expression of the antigen defined by monoclonal antibody F10.44.2, is on human chromosome 11 , 1982, European journal of immunology.

[52]  B. Imhof,et al.  Embryonic Colonization of the Thymus by T Cell Progenitors as a Model for Metastasis , 1992 .

[53]  S. Jalkanen,et al.  Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. , 1988, Journal of immunology.

[54]  C. June,et al.  IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. , 1990, Journal of immunology.

[55]  P. Herrlich,et al.  A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps , 1993, The Journal of cell biology.

[56]  C. Underhill,et al.  The hyaluronate receptor is preferentially expressed on proliferating epithelial cells , 1989, The Journal of cell biology.

[57]  L. Picker,et al.  A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins , 1989, Cell.

[58]  K. Ishihara,et al.  Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition , 1992, The Journal of cell biology.

[59]  R. Humphries,et al.  Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells , 1991, The Journal of experimental medicine.

[60]  Tae H. Lee,et al.  A novel secretory tumor necrosis factor-inducible protein (TSG-6) is a member of the family of hyaluronate binding proteins, closely related to the adhesion receptor CD44 , 1992, The Journal of cell biology.

[61]  I. Hart,et al.  Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. , 1991, Cancer research.

[62]  I. Hart,et al.  Biology of tumour metastasis , 1992, The Lancet.

[63]  R. Hynes,et al.  In vitro splicing of fibronectin pre-mRNAs. , 1990, Nucleic Acids Research.

[64]  I. Stamenkovic,et al.  CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.